NDC 50090-5960-01 - Losartan Potassium and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-5960
- Requested NDC
- 50090-5960-01
- Package NDCs from labels
- 50090-5960-0, 50090-5960-2, 50090-5960-1, 50090-5960-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-05-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium and Hydrochlorothiazide - A-S Medication Solutions | A-S Medication Solutions | 2024-05-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-5960-0 | Losartan Potassium and Hydrochlorothiazide | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 50090-5960-1 | Losartan Potassium and Hydrochlorothiazide | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 50090-5960-2 | Losartan Potassium and Hydrochlorothiazide | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5960 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE) TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 7 | Current NDC, Legacy NDC, 3 package rows | 20240511_1bb08103-04ee-47a6-a9ad-290e169feb51.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-5960-0 | EA - Each | 50090-5960 | 236055f1-416d-4476-9b0a-73e1e0487b4e | 1 | 2022-07-06 |
| 50090-5960-1 | EA - Each | 50090-5960 | 7d68ca49-dafa-447b-a05c-8d0bc0a3e141 | 1 | 2022-07-06 |
| 50090-5960-2 | EA - Each | 50090-5960 | 4e10ae2d-dd32-475b-9ed6-a7938f3dac25 | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Losortan Potassium | LOSARTAN POTASSIUM | Preferred Pharmaceuticals Inc. | 25651749-8950-43ff-bcbd-3bb85f57a360 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| KIEHLS DERMATOLOGIST SOLUTIONS BETTER SCREEN MINER ALL UV SERUM BROAD SPECTRUM SPF 50 PLUS MINERAL SUNSCREEN | TITANIUM DIOXIDE AND ZINC OXIDE | LOreal USA Products Inc | 294e6049-12b5-4b45-ae00-8ee1d9d2a1a4 | 2026-05-29 | Warnings | 15FIX9V2JP |
| Irbesartan and Hydrochlorothiazide | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 85494404-484c-45a1-8487-f9eb2a76490d | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium | LOSARTAN POTASSIUM | Preferred Pharmaceuticals, Inc. | fe1df76d-4925-444d-8e30-9dd07f205fb7 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | PD-Rx Pharmaceuticals, Inc. | f9a92771-5c73-4f17-ac38-29fabfd4a919 | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 5f7612dc-dccf-49e2-b541-3dab9dc1f97a | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Coupler LLC | 52b90789-2902-3ab9-e063-6394a90a5abb | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| O HUI DAY SHIELD PERFECT SUN BLACK BROAD SPECTRUM SPF 50 SUNSCREEN | OCTISALATE, OCTOCRYLENE, TITANIUM DIOXIDE, ZINC OXIDE | LG H&H Co., Ltd. | 52ba9423-8b9b-38f7-e063-6394a90a95da | 2026-05-26 | Warnings | 15FIX9V2JP |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Preferred Pharmaceuticals Inc. | 5956a107-0f7b-49e7-b9c9-36790349b06e | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| LISINOPRIL AND HYDROCHLOROTHIAZIDE | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals, Inc. | 5aa18b0b-4688-493a-a5ae-cb056ea6c0e3 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Preferred Pharmaceuticals Inc. | 9207c3bc-e12e-4017-8b85-0f928e744f64 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Preferred Pharmaceuticals Inc. | fc4d7d0e-78a6-4d7e-ba53-aeeb008aa2dc | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | ScieGen Pharmaceuticals Inc | 52332190-2a12-d205-e063-6394a90ab7c5 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Olmesartan Medoxomil and Hydrochlorothiazide | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 77e71a2e-8370-4f7a-a5e4-93d86bd37dad | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 544b75eb-55f1-4164-9b83-39f6bc5fb479 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Spironolactone and Hydrochlorothiazide | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | c5258ea3-3aac-48fd-be5a-f8e4a47ca94a | 2026-05-21 | Warnings, Adverse reactions | 0J48LPH2TH |
| Mineral SPF 30 Moisturizer | MINERAL SPF 30 MOISTURIZER | Dont Run Out Inc (DBA: Public Goods) | 52462e7e-0c2c-6b64-e063-6394a90a4230 | 2026-05-21 | Warnings | 15FIX9V2JP |
| DRMTLGY Radiance Powder | TITANIUM DIOXIDE, ZINC OXIDE | DRMTLGY | 15bda8d5-8c3c-6ba5-e063-6394a90a82d9 | 2026-05-21 | Warnings | 15FIX9V2JP |
| Losartan Potassium | LOSARTAN POTASSIUM | PD-Rx Pharmaceuticals, Inc. | abb56236-f2fe-45b5-93ac-35fd661f8992 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| SkinCeuticals Future Mineral UV Defense Invisble Sunscreen Mineral Filters Broad Spectrum SPF 50 | TITANIUM DIOXIDE AND ZINC OXIDE | L'Oreal USA Products Inc | 0b92a940-0dd4-4266-bd47-88c27def62c0 | 2026-05-20 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.